GlassScriptPhysician profile
Abhishek Aphale
NPI 1437300993
$295.36
in general payments reported to CMS, 2019-2025
7 companies · $86.03 in 2025
The $86.03 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.89 · 2020: $14.95 · 2022: $57.00 · 2023: $31.23 · 2024: $62.26 · 2025: $86.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $83.03 | 2022-2024 | Odomzo, Blu-U |
| Lifenet Health | $65.69 | 2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $44.07 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Genentech USA, INC. | $42.94 | 2019-2020 | |
| Lilly USA, LLC | $23.39 | 2022 | |
| Adaptive Biotechnologies Corporation | $20.34 | 2025 | Clonoseq |
| Genzyme Corporation | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Aphale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.